Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:30:15 EST Fri 23 Jan 2026
Enter Symbol
or Name
USA
CA



Q:SDGR - SCHRODINGER INC - https://ir.schrodinger.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SDGR - Q0.116.30·17.710.116.42-0.91-5.31,170.418,83511,01517.435  17.435  16.3828.45  15.9919:51:36Jan 1215 min RT 2¢

Recent Trades - Last 10 of 11015
Time ETExPriceChangeVolume
19:51:36Q16.42-0.9120
19:50:05Q16.43-0.9058
19:34:21Q16.39-0.941,822
19:34:21Q16.389-0.9411,822
19:34:21Q16.389-0.941178
19:34:21Q16.39-0.943,753
19:34:21Q16.39-0.94147
19:34:21Q16.38-0.95300
19:34:21Q16.38-0.9570
19:33:27Q16.39-0.941

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-12 08:30U:SDGRNews ReleaseSchrodinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
2026-01-09 07:00U:SDGRNews ReleaseSchrodinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
2025-12-17 08:30U:SDGRNews ReleaseSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-12-09 11:57U:SDGRNews ReleaseBeyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
2025-11-06 08:30U:SDGRNews ReleaseSchrodinger to Present at Jefferies London Healthcare Conference
2025-11-05 16:05U:SDGRNews ReleaseSchrodinger Reports Third Quarter 2025 Financial Results
2025-10-22 08:30U:SDGRNews ReleaseSchrodinger to Announce Third Quarter 2025 Financial Results on November 5
2025-10-15 08:30U:SDGRNews ReleaseSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-09-18 08:30U:SDGRNews ReleaseSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-08-27 08:30U:SDGRNews ReleaseSchrodinger to Present at Morgan Stanley Global Healthcare Conference
2025-08-15 16:30U:SDGRNews ReleaseSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-08-14 07:00U:SDGRNews ReleaseSchrodinger Announces Discontinuation of SGR-2921 Program
2025-08-06 16:05U:SDGRNews ReleaseSchrodinger Reports Second Quarter 2025 Financial Results
2025-07-25 08:30U:SDGRNews ReleaseSchrodinger to Announce Second Quarter 2025 Financial Results on August 6
2025-07-18 08:00U:SDGRNews ReleaseSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-07-17 08:00U:SDGRNews ReleaseAjax Therapeutics and Schrodinger Expand Research Collaboration to Include Additional JAK Target
2025-06-27 08:00U:SDGRNews ReleaseSchrodinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenstrom Macroglobulinemia
2025-06-17 08:30U:SDGRNews ReleaseSchrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2025-06-12 07:00U:SDGRNews ReleaseSchrodinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress